Literature DB >> 23343137

Paradoxical reaction to etanercept: development of pyoderma gangraenosum during therapy of psoriasis arthritis.

Lutz Kowalzick, Julia Bertolini, Christine Baumann, Beate Walther, Beate Truhm, Lena Eickenscheidt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23343137     DOI: 10.1111/ddg.12032

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN: 1610-0379            Impact factor:   5.584


× No keyword cloud information.
  5 in total

Review 1.  Inflammatory Joint Disorders and Neutrophilic Dermatoses: a Comprehensive Review.

Authors:  Massimo Cugno; Roberta Gualtierotti; Pier Luigi Meroni; Angelo Valerio Marzano
Journal:  Clin Rev Allergy Immunol       Date:  2018-04       Impact factor: 8.667

Review 2.  Pyoderma gangrenosum: pathogenetic oriented treatment approaches.

Authors:  Uwe Wollina; Georgi Tchernev
Journal:  Wien Med Wochenschr       Date:  2014-06-05

Review 3.  Pyoderma gangrenosum and pyogenic arthritis presenting as severe sepsis in a rheumatoid arthritis patient treated with golimumab.

Authors:  Anastasia Skalkou; Sofia-Magdalini Manoli; Alexandros Sachinidis; Vasilios Ntouros; Konstantinos Petidis; Eleni Pagkopoulou; Efstratios Vakirlis; Athina Pyrpasopoulou; Theodoros Dimitroulas
Journal:  Rheumatol Int       Date:  2017-10-26       Impact factor: 2.631

Review 4.  Pyoderma gangrenosum: challenges and solutions.

Authors:  Ana Gameiro; Neide Pereira; José Carlos Cardoso; Margarida Gonçalo
Journal:  Clin Cosmet Investig Dermatol       Date:  2015-05-28

5.  Paradoxical Skin Reaction to Certolizumab, an Overlap of Pyoderma Gangrenosum and Psoriasis in a Young Woman Treated for Ankylosing Spondylitis: Case Report with Literature Review.

Authors:  Anna Gawdzik; Małgorzata Ponikowska; Alina Jankowska-Konsur; Zdzisław Woźniak; Joanna Maj; Jacek C Szepietowski
Journal:  Dermatol Ther (Heidelb)       Date:  2020-05-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.